ZYME - Zymeworks Inc

Healthcare - Sector

ZYME is currently covered by 7 analysts with average potential upside of $17.01 (87.24%) backed by 29 price targets and 50 ratings. Analyst's average stock valuation to be materialised ratio is 44.73% with an average time for price targets to be met of 142.57 days.

Most recent stock forecast was given by ROBERT BURNS from HCWAINWRIGHT on 01-Nov-2022.

Highest price target for ZYME is 56, Lowest price target is 5, average price target is 30.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

8

$0.16 (2.04%)

40

26 days ago

2/8 (25%)

$18.23 (108.08%)

77

Buy

8

$0.16 (2.04%)

1 months 6 days ago

2/7 (28.57%)

$8.34 (29.29%)

32

Buy

27

$19.16 (244.39%)

28

2 months 29 days ago

5/10 (50%)

$14.15 (138.28%)

242

Buy

45

$37.16 (473.98%)

56

9 months 18 days ago

2/6 (33.33%)

$22.13 (138.43%)

373

Buy

74

$66.16 (843.88%)

74

11 months 17 days ago

3/7 (42.86%)

$25.27 (112.18%)

105

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login